Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

EBV/LMP-specific T cells maintain remissions of T- and B-cell EBV lymphomas after allogeneic bone marrow transplantation

Lauren P. McLaughlin, Rayne Rouce, Stephen Gottschalk, Vicky Torrano, George Carrum, Meng-Fen Wu, Fahmida Hoq, Bambi Grilley, Andrea M. Marcogliese, Patrick J. Hanley, Adrian P. Gee, Malcolm K. Brenner, Cliona M. Rooney, Helen E. Heslop, Catherine M. Bollard

Blood (2018) 132 (22): 2351–2361.

https://doi.org/10.1182/blood-2018-07-863654

Published: 2018

Journal Articles

Rituximab, Fludarabine, Mitoxantrone, and Dexamethasone (R-FND) for Relapsed Indolent Lymphomas (RIL).

F.B. Hagemeister, MD, P. McLaughlin, MD, L. Fayad, MD, F. Samaniego, MD, N. Dang, MD, A. Goy, MD, J. Romaguera, MD, B. Pro, MD, V. Beasley, R.N., F. Cabanillas, MD, M. Rodriguez, MD

Blood (2005) 106 (11): 941.

https://doi.org/10.1182/blood.V106.11.941.941

Published: 2005

Journal Articles

ASHAP: A Regimen for Cytoreduction of Refractory or Recurrent Hodgkin’s Disease

J. Rodriguez, M.A. Rodriguez, L. Fayad, P. McLaughlin, F. Swan, A. Sarris, J. Romaguera, B. Andersson, F. Cabanillas, F.B. Hagemeister

Blood (1999) 93 (11): 3632–3636.

https://doi.org/10.1182/blood.V93.11.3632

Published: 1999

Journal Articles

Follicular Large Cell Lymphoma: An Aggressive Lymphoma That Often Presents With Favorable Prognostic Features

J. Rodriguez, P. McLaughlin, F.B. Hagemeister, L. Fayad, M.A. Rodriguez, M. Santiago, M. Hess, J. Romaguera, F. Cabanillas

Blood (1999) 93 (7): 2202–2207.

https://doi.org/10.1182/blood.V93.7.2202

Published: 1999

Journal Articles

A pilot study of high-dose interleukin-3 treatment of relapsed follicular small cleaved-cell lymphoma: hematologic, immunologic, and clinical results [published erratum appears in Blood 1996 Jun 1;87(11):4922]

A Younes, A Sarris, U Consoli, A Rodriguez, P McLaughlin, Y Huh, S Starry, F Cabanillas, M Andreeff

Blood (1996) 87 (5): 1698–1703.

https://doi.org/10.1182/blood.V87.5.1698.1698

Published: 1996

Journal Articles

Clinical, biologic, and histologic features of late relapses in diffuse large cell lymphoma

F Cabanillas, WS Velasquez, FB Hagemeister, P McLaughlin, JR Redman

Blood (1992) 79 (4): 1024–1028.

https://doi.org/10.1182/blood.V79.4.1024.1024

Published: 1992

Journal Articles

Stages I and II diffuse large cell lymphomas: prognostic factors and long-term results with CHOP-bleo and radiotherapy

WS Velasquez, LM Fuller, S Jagannath, SL Tucker, LB North, FB Hagemeister, P McLaughlin, F Swan, JR Redman, MA Rodriguez

Blood (1991) 77 (5): 942–947.

https://doi.org/10.1182/blood.V77.5.942.942

Published: 1991

Journal Articles

Risk classification as the basis for clinical staging of diffuse large- cell lymphoma derived from 10-year survival data

WS Velasquez, S Jagannath, SL Tucker, LM Fuller, LB North, JR Redman, F Swan, FB Hagemeister, P McLaughlin, F Cabanillas

Blood (1989) 74 (2): 551–557.

https://doi.org/10.1182/blood.V74.2.551.551

Published: 1989

Journal Articles

Cytogenetic features of Hodgkin's disease suggest possible origin from a lymphocyte

F Cabanillas, S Pathak, J Trujillo, G Grant, A Cork, FB Hagemeister, WS Velasquez, P McLaughlin, J Redman, R Katz

Blood (1988) 71 (6): 1615–1617.

https://doi.org/10.1182/blood.V71.6.1615.1615

Published: 1988

Journal Articles

Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP)

WS Velasquez, F Cabanillas, P Salvador, P McLaughlin, M Fridrik, S Tucker, S Jagannath, FB Hagemeister, JR Redman, F Swan

Blood (1988) 71 (1): 117–122.

https://doi.org/10.1182/blood.V71.1.117.117

Published: 1988

Journal Articles

The gene located at chromosome 18 band q21 is rearranged in uncultured diffuse lymphomas as well as follicular lymphomas

MS Lee, MB Blick, S Pathak, JM Trujillo, JJ Butler, RL Katz, P McLaughlin, FB Hagemeister, WS Velasquez, A Goodacre

Blood (1987) 70 (1): 90–95.

https://doi.org/10.1182/blood.V70.1.90.90

Published: 1987

Journal Articles

Myeloma protein kinetics following chemotherapy

P McLaughlin, R Alexanian

Blood (1982) 60 (4): 851–855.

https://doi.org/10.1182/blood.V60.4.851.851

Published: 1982

NARROW

EBV/LMP-specific T cells maintain remissions of T- and B-cell EBV lymphomas after allogeneic bone marrow transplantation

Rituximab, Fludarabine, Mitoxantrone, and Dexamethasone (R-FND) for Relapsed Indolent Lymphomas (RIL).

ASHAP: A Regimen for Cytoreduction of Refractory or Recurrent Hodgkin’s Disease

Follicular Large Cell Lymphoma: An Aggressive Lymphoma That Often Presents With Favorable Prognostic Features

A pilot study of high-dose interleukin-3 treatment of relapsed follicular small cleaved-cell lymphoma: hematologic, immunologic, and clinical results [published erratum appears in Blood 1996 Jun 1;87(11):4922]

Clinical, biologic, and histologic features of late relapses in diffuse large cell lymphoma

Stages I and II diffuse large cell lymphomas: prognostic factors and long-term results with CHOP-bleo and radiotherapy

Risk classification as the basis for clinical staging of diffuse large- cell lymphoma derived from 10-year survival data

Cytogenetic features of Hodgkin's disease suggest possible origin from a lymphocyte

Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP)

The gene located at chromosome 18 band q21 is rearranged in uncultured diffuse lymphomas as well as follicular lymphomas

Myeloma protein kinetics following chemotherapy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only